BiotechTube
cmbio

cmbio

Copenhagen, Denmark· Est.
cmbio.io
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $12.8M

Overview

Cmbio is a private, service-oriented biotech company leveraging multi-omics and microbiome science to drive research in health and sustainability. With a team of over 100 experts and labs in the US and Denmark, it offers a comprehensive suite of analytical services, from sample collection kits to integrative systems biology, for academic and commercial clients globally. The company is positioned as a leading research partner, enabling discoveries in areas like women's health, gut health, and animal health through its data science and global infrastructure.

Women's HealthInfant HealthGut HealthAnimal HealthMultiple Sclerosis

Technology Platform

Integrated multi-omics and microbiome analysis platform combining metagenomics, metabolomics, transcriptomics, proteomics, and epigenomics with advanced bioinformatics, data science, and a cloud-based ecosystem for end-to-end research services.

Funding History

2
Total raised:$12.8M
Series A$10M
Seed$2.8M

Opportunities

The rapidly expanding global microbiome research market and the growing necessity for integrated multi-omics analysis to translate microbial insights into actionable health solutions present a significant growth opportunity.
Cmbio can capitalize on this by forming deep partnerships with biopharma companies moving microbiome therapies into clinical trials, where complex biomarker and mechanism data is critical.

Risk Factors

Key risks include high competition from both large CROs and niche bioinformatics firms, reliance on continued investment in the microbiome sector which is subject to scientific and funding cycles, and the operational challenge of scaling an expert-driven service model while maintaining technological leadership in a fast-evolving field.

Competitive Landscape

Cmbio competes in the omics services market against large, diversified contract research organizations (CROs) with omics divisions, specialized microbiome analytics companies, and academic core facilities. Its differentiation lies in its dedicated focus on microbiome multi-omics integration, its combined wet-lab and bioinformatics expertise, and its positioning as a collaborative research partner rather than just a service vendor.

More companies in Proteomics & Protein Engineering →More companies in Denmark →